Position in GRFS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,737,977
-$3,103,570 QoQ
Shares Held
2,646,607
-2.8% QoQ
Ownership
0.389%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 164 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,542,546,853 across 13 Drug Manufacturers - General names. GRFS ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
5,307,020 | $1,006,317,132 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,966,523 | $509,698,205 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,585,846 | $494,716,446 | |
| 4 | NVO |
Novo Nordisk A S
|
8,270,785 | $396,501,432 | |
| 5 | LLY |
ELI LILLY & Co
|
249,935 | $299,779,562 | |
| 6 | JNJ |
Johnson & Johnson
|
1,127,893 | $286,450,985 | |
| 7 | ABBV |
AbbVie Inc.
|
856,797 | $215,604,397 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
959,904 | $121,274,271 |
All Filings in GRFS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,737,977 | 2,646,607 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $21,841,547 | 2,723,385 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $25,604,572 | 2,738,457 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $27,894,424 | 2,800,645 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,234,268 | 579,012 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,757,343 | 669,106 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,707,661 | 363,933 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,982,111 | 448,436 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $906,816 | 143,711 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,506,529 | 375,229 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $907,506 | 78,504 | Shares | Defined | 2024-02-14 | |
| 2022-06-30 | $3,193,486 | 268,812 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $19,279,825 | 1,650,670 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $23,680,173 | 2,108,653 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $32,731,235 | 2,240,331 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,093,235 | 408,832 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,203,866 | 590,160 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $12,984,747 | 704,162 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $19,393,760 | 1,117,796 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $16,300,540 | 893,670 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $12,571,629 | 624,212 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||